3 completed, 3 not yet recruiting, 1 unknown. 4 Phase 2, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Not yet recruiting 2 |
| Phase 1 | 2 | Not yet recruiting 2 |
| Phase 4 | 1 | Unknown 1 |
Follow Tenofovir: new trials by email Literature Review of Tenofovir trials Research Report on Tenofovir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tenofovir Exposures in Advanced Kidney Disease Study Plasma sampling for tenofovir and emtricitabine, Descovy - Tenofovir, Tenofovir Alafenamide Fumarate | Not yet recruiting | King's College Hospital NHS Trust | 50 | 2026-11-01 | 2026-09-10 | |
| Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases. PD-1 Inhibitor Combined with Tenofovir, Chidamide, and Lenalidomide for the Treatment of EBV Infectious Diseases. - Epstein-Barr Virus (EBV) Infection, PD-1 Inhibitor | Phase 1 / Phase 2 | Not yet recruiting | The Affiliated Hospital of Xuzhou Medical University | 30 | 2025-09-01 | 2025-08-21 |
| Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders. PD-1 Inhibitor Combined with Tenofovir, Chidamide, and Lenalidomide for the Treatment of EBV-Associated Lymphoproliferative Disorders. - EBV-Associated Lymphoproliferative Disorders, PD-1 Inhibitor | Phase 1 / Phase 2 | Not yet recruiting | The Affiliated Hospital of Xuzhou Medical University | 50 | 2025-09-01 | 2025-08-21 |
| CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR Oral F/TDF Pills, TFV rectal douche - Tenofovir | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 150 | 2024-10-29 | 2026-10-23 |
| Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B. Tenofovir Disoproxil Fumarate - Hepatitis B, Tenofovir | Phase 2 | Completed | University of Oxford | 27 | 2021-01-08 | 2024-03-27 |
| Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV) Covid19, SARS-CoV Infection | Completed | Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud | 100 | 2020-03-01 | 2021-03-25 | |
| TDF Dose Adjustment VS. Switching to TAF in TDF-experienced CHB Patients With Renal Impairment Switching to Tenofovir Alafenamide - Renal Insufficiency, Tenofovir | Phase 4 | Unknown | Mahidol University | 80 | 2019-11-09 | 2022-03-08 |
Renal Insufficiency (2) · COVID-19 (1) · Epstein-Barr Virus Infections (1) · Hepatitis B (1) · Infections (1) · Renal Insufficiency, Chronic (1) · Severe Acute Respiratory Syndrome (1)
Virus Diseases (3) · DNA Virus Infections (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Infections (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Digestive System Diseases (1)
Tenofovir (3) · Lenalidomide (2) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (2) · emtricitabine tenofovir alafenamide (1)
The Affiliated Hospital of Xuzhou Medical University (2) · Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud (1) · King's College Hospital NHS Trust (1) · Mahidol University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Oxford (1)
Thailand (2) · Peru (1) · United Kingdom (1) · United States (1)
Mario Cornejo-Giraldo, M.D. (1) · Watcharasak Chotiyaputta, Asso Prof (1)